Health condition
Amyloidosis testing pathway
Amyloidosis is confirmed and typed through a structured pathway - blood light chain tests, tissue biopsy, nuclear imaging and often genetics - because treatment depends entirely on which type of amyloid you have.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Typing the amyloid is as important as finding it - AL and ATTR treatments are completely different
-
Core tests: serum free light chains, immunofixation, biopsy with Congo red staining, DPD scan
-
Mass spectrometry at a specialist centre is the gold standard for typing tissue amyloid
-
The UK National Amyloidosis Centre coordinates confirmation, typing and staging
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
Suspected amyloidosis triggers two parallel questions: is amyloid present, and what is it made of? Blood and urine tests look for a clonal light chain signature; biopsy of an affected organ or a simple fat pad confirms amyloid with Congo red staining; and a DPD bone scan assesses cardiac involvement, capable of confirming ATTR non-invasively when light chain tests are clean.
Diagnosis and treatment routes
Typing errors are the pathway’s great hazard - treating ATTR with chemotherapy or missing treatable AL both cause real harm - so ambiguous cases go to mass spectrometry, which identifies the protein directly from tissue. Staging blood markers then size up cardiac risk and guide treatment intensity. If your diagnosis was made without formal typing, asking for specialist centre review is entirely appropriate. In many parts of the UK, routine NHS referrals for this kind of problem can take months, whereas an initial appointment with a private consultant is typically available within around two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant haematologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Amyloidosis testing pathway.
Quick, plain-English answers to what people ask us most.
-
What is the amyloidosis testing pathway?
The amyloidosis testing pathway is the structured series of investigations used to confirm a diagnosis of amyloidosis, identify its specific type, and assess which organs are affected, guiding appropriate treatment.
-
Why is identifying the specific type of amyloidosis important?
Different types of amyloidosis, such as AL and ATTR, have very different causes, treatments, and prognoses, so accurately identifying the specific type is essential for choosing the right management approach.
-
What tests are used in the amyloidosis testing pathway?
Testing typically includes blood and urine tests for abnormal proteins, imaging such as echocardiography or specialised nuclear scans, and often a tissue biopsy to confirm amyloid deposits and determine the specific protein type involved.
-
Is a biopsy always needed to diagnose amyloidosis?
In many cases, yes, a biopsy showing characteristic amyloid deposits, along with specific staining to identify the protein type, remains the most definitive way to confirm diagnosis, though some newer imaging techniques can support diagnosis in specific situations.
-
How long does the amyloidosis testing pathway take?
The full pathway, from initial suspicion to confirmed diagnosis and organ assessment, can take several weeks, reflecting the number of specialised tests often needed for accurate typing and staging.
-
Why might amyloidosis be difficult to diagnose initially?
Symptoms can be vague and overlap with many other conditions, and amyloidosis is relatively rare, meaning it isn't always considered early, which is why a structured, thorough testing pathway is valuable once suspected.
-
Amyloidosis testing vs testing for other causes of organ failure — what's the difference?
General organ failure testing looks broadly at function, while amyloidosis-specific testing includes targeted tests like biopsy with specific protein staining and blood tests for abnormal light chains, aimed at identifying this particular underlying cause when standard testing doesn't explain the clinical picture.
-
What happens after amyloidosis type is confirmed?
Once the specific type is identified, further assessment of organ involvement (heart, kidney, nerves, gut) guides a tailored treatment plan specific to that amyloidosis type and its severity.
-
Can amyloidosis testing be done privately?
Yes, most components of the pathway, including blood tests, imaging, and biopsy, can be arranged privately, often more quickly than through standard NHS routes, though results still need specialist interpretation.
-
When should I seek referral for amyloidosis testing, and how quickly can I be seen privately?
See a doctor if amyloidosis is suspected based on symptoms or unexplained organ dysfunction. NHS referral to a specialist amyloidosis centre can take several weeks, while private specialist assessment is often available within about two weeks.